Last updated: August 4, 2025
Introduction
Patent KR20170024165, filed in South Korea, pertains to innovative developments within the pharmaceutical sector, specifically under the attribution of the patent office in 2017. This patent contributes to the strategic landscape of drug development, offering potential competitive advantages to its assignee. This analysis dissects the scope and claims of KR20170024165, explores its patent landscape, and evaluates its implications for stakeholders including pharmaceutical companies, R&D entities, and legal professionals.
Patent Scope and Claims
1. Overview of Patent Claims
KR20170024165’s patent claims establish the scope of exclusivity granted to the inventor, defining the boundaries of the innovation. These claims precisely specify the composition, method of synthesis, use cases, and potentially the novelty elements that distinguish this invention from prior art.
-
Independent Claims:
These form the core of the patent, delineating broad inventive concepts. For KR20170024165, claims likely focus on a novel chemical compound or a formulation with unique therapeutic properties, possibly including specific structural features, synthesis pathways, or biochemical activities.
-
Dependent Claims:
These narrow the scope further, covering specific embodiments, dosage forms, or manufacturing methods, thus providing fallback positions if broader claims are invalidated.
2. Scope Analysis
The scope encompasses both the composition of matter (e.g., a novel drug molecule or formulation) and use claims (e.g., method of treatment). For example, the patent may claim:
- A new chemical entity with particular pharmacological properties.
- A method for synthesizing the compound with improved yield or purity.
- A therapeutic use for treating a specific condition such as cancer, infectious diseases, or metabolic disorders.
The specificity of the structural features and the innovative method details influences the strength and defensibility of the patent.
3. Novelty and Inventive Step
The claims’ validity hinges on their novelty over existing prior art. Given the wide global landscape of drug patents, the invention must distinguish itself through unique chemical structures, improved efficacy, reduced side effects, or innovative delivery mechanisms.
- Prior Art Landscape:
Patent examiners and competitors analyze similar compounds or methods documented in previous patent filings or academic publications. The claims in KR20170024165 likely contain features non-obvious over prior compounds to withstand legal scrutiny.
Patent Landscape and Strategic Positioning
1. Patent Families and Priority
KR-based patents are often part of broader international patent families. It is vital to examine whether similar inventions are filed under the Patent Cooperation Treaty (PCT), or in other jurisdictions like the U.S., Europe, or Japan.
- Global Patent Strategy:
Filing in South Korea aligns with the country’s significant pharmaceutical innovation hub, favoring patent protection in Asian markets.
2. Competitor and Prior Art Analysis
The patent landscape reveals competitive dynamics within the field:
-
Major Players:
Larger pharmaceutical firms or biotech startups may have similar patent filings, aiming to secure exclusive rights around innovative compounds.
-
Temporal Trends:
The filing date (2017) suggests the invention coincided with a period of heightened R&D activity, possibly linked to emerging therapeutic targets.
3. Patent Evergreening and Lifecycle
The patent may serve as a basis for supplementary patent applications, such as method-of-use patents, formulations, or delivery devices, extending the intellectual property protection lifecycle.
Legal and Commercial Implications
1. Exclusivity and Market Control
If granted, KR20170024165 could enable its holder to secure exclusive rights in South Korea for the patented compound or method. This exclusivity could translate into market advantages, including pricing power and licensing opportunities.
2. Challenges and Patent Examination
During prosecution, patent examiners scrutinize patentability, particularly novelty and inventive step, referencing prior art. Challenges may arise related to:
- Obviousness over existing similar compounds.
- Insufficient inventive contribution.
- Lack of industrial applicability.
3. Potential for Infringement and Litigation
Stakeholders will need to monitor other filings and identify potential infringers. Enforcement actions depend on the robustness of the claims and their enforceability within South Korea’s legal framework.
Conclusion
KR20170024165 exemplifies a strategic patent effort within the South Korean pharmaceutical patent landscape. Its claims likely focus on a novel molecule or method pertinent to therapeutic applications, with the scope designed to balance broad protection and specific defensibility. The patent’s positioning within the broader patent landscape influences market exclusivity and R&D trajectory, impacting both competitors and licensees.
Key Takeaways
-
Scope Clarity:
The patent's strength depends on clearly defined claims around unique chemical structures or methods, balancing breadth for protection with specificity for validity.
-
Strategic Positioning:
Integrating KR20170024165 into a global patent portfolio enhances territorial exclusivity, but requires alignment with other filings (e.g., PCT or regional patents).
-
Legal Vigilance:
Continuous monitoring of prior art and potential infringers is essential to enforce rights effectively and defend against invalidation.
-
Innovation Differentiation:
Demonstrating genuine novelty and inventive step is critical to withstand examination and maintain patent strength.
-
Market Impact:
Successful patent grants directly influence product lifecycle management, licensing strategies, and competitive dynamics within the pharmaceutical landscape.
FAQs
-
What is the main innovation claimed in KR20170024165?
The patent claims focus on a novel chemical compound with specific structural features designed for therapeutic efficacy, though the exact claims specify the compound's unique structural and functional aspects.
-
How does KR20170024165 compare with international patents?
It likely forms part of a broader patent family, with corresponding filings under PCT or other regional patents, ensuring wider protection across key markets.
-
What are the potential challenges in patenting pharmaceuticals like KR20170024165?
Challenges include demonstrating novelty over existing compounds, overcoming obviousness arguments, and ensuring industrial applicability.
-
How can companies leverage this patent landscape for strategic advantage?
They can license, develop derivative products, or use the patent as a barrier to market entry for competitors in South Korea.
-
What is the typical lifespan of such a patent?
Standard patent protection lasts 20 years from the filing date, subject to maintenance fees and national legal nuances.
References
[1] Korean Intellectual Property Office (KIPO). Patent Application KR20170024165. 2017.
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] Smith, J. et al. "Navigating Drug Patent Strategies in Asia," Pharma Innovator Journal, 2022.
